Use of mannosylated liposomes for in vivo targeting of a macrophage activator and control of artificial pulmonary metastases
- 22 January 1987
- journal article
- research article
- Published by Elsevier in Annales de l'Institut Pasteur / Immunologie
- Vol. 138 (3) , 437-450
- https://doi.org/10.1016/s0769-2625(87)80054-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Production and characterization of cytostatic protein factors released from human monocytes during exposure to lipopolysaccharide and muramyl dipeptideCellular Immunology, 1985
- Phospholipid Vesicle Targeting Using Synthetic Glycolipid and Other DeterminantsAnnals of the New York Academy of Sciences, 1985
- Muramyl peptides: Immunomodulators, sleep factors, and vitaminsMedicinal Research Reviews, 1984
- The recognition of red blood cells by macrophages: role of phosphatidylserine and possible implications of membrane phospholipid asymmetryBiology of the Cell, 1984
- Expression of a mannosyl-fucosyl receptor for endocytosis on cultured primary macrophages and their hybrids.The Journal of cell biology, 1982
- In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomesCellular Immunology, 1981
- Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouseInternational Journal of Immunopharmacology, 1979
- Total synthesis and adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1975
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- Fate of Protein‐Containing Liposomes Injected into RatsEuropean Journal of Biochemistry, 1972